Inactive Instrument

Company tella, Inc.

Equities

2191

JP3545900007

Biotechnology & Medical Research

Business Summary

tella, Inc. is a Japan-based company mainly engaged in the provision of techniques and operational knowhow associated with cell medicines, as well as the research and development of regenerative medicine and cell medicine. The Company operates through three business segments. The Cell Medicine segment is engaged in the provision of cancer treatment technology and operational method centered on dendritic cell vaccine therapy. This segment is also engaged in the provision of Services for contract medical institutions, such as cell culture system maintenance support services, management system maintenance support services and disease support services. The Medical Support segment is mainly engaged in the provision of drug development services (CROs) and genetic testing services. The Pharmaceutical segment is engaged in the development of the dendritic cell vaccine for regulatory approval as a product for cancer regenerative medicine.

Number of employees: 30

Managers

Managers TitleAgeSince
President 33 22-03-28
Chief Administrative Officer - -

Members of the board

Members of the board TitleAgeSince
Director/Board Member 38 21-02-28
Director/Board Member 60 21-02-28
President 33 22-03-28
Director/Board Member 37 22-02-28

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 25,327,356 23,737,013 ( 93.72 %) 343 ( 0.001354 %) 93.72 %

Company contact information

tella, Inc.

Shinjuku Island Tower, 20/F 6-5-1 Nishi-Shinjuku

163-1320, Tokyo

+

https://www.tella.jp/en
address tella, Inc.(2191)